Author:
Bagaria Vivek,Mathur Purva,Madan Karan,Kumari Minu,Sagar Sushma,Gupta Amit,Soni Kapil Dev,Bhattacharjee Hemanga,Kumar Subodh
Funder
All-India Institute of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Aukema TS, Beenen LF, Hietbrink F, Leenen LP (2011) Validation of the Thorax Trauma Severity Score for mortality and its value for the development of acute respiratory distress syndrome. Open Access Emerg Med 3:49–53
2. Claus RA, Bockmeyer CL, Budde U, Kentouche K, Sossdorf M, Hilberg T et al (2009) Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thromb Haemost 101:239–247
3. Anderson D (2001) WHO International Programme on Chemical Safety. Biomarkers in risk assessment: validity and validation. World Heath Organisation. http://www.inchem.org/documents/ehc/ehc/ehc222. Accessed 10 April 2017
4. Bajaj MS, Tricomi SM (1999) Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intensive Care Med 25:1259–1266
5. Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, de Backer WA, Lauwerys R, Flower RJ, Bernard A (1995) Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 8:1647–1653
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献